Aprepitant Capsules - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB506246547

Publication Date:

June 12, 2024

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Aprepitant is prescribed for patients 12 years of age and older, in combination with other antiemetic agents to help prevent nausea and vomiting caused by certain chemotherapy medicines. It is also prescribed for adults to prevent nausea and vomiting after surgery. Aprepitant is not used for established nausea and vomiting. Aprepitant is not for chronic continuous administration.
The global market for Aprepitant Capsules was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Aprepitant capsules are widely used for the prevention of nausea and vomiting during both the induction and subsequent phases of chemotherapy. With the continuous evolution of the oncology field, Aprepitant capsules have solidified their position in the market, leading to a gradual expansion of its market size. Its outstanding clinical performance has resulted in sustained sales growth, establishing it as a key player in the management of nausea and vomiting. Furthermore, as research into supportive therapies for cancer treatment advances, Aprepitant capsules hold the potential for further application and development in a broader spectrum of nausea and vomiting prevention, ultimately offering enhanced quality of life for patients.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aprepitant Capsules, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Aprepitant Capsules by region & country, by Type, and by Application.
The Aprepitant Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aprepitant Capsules.
Market Segmentation
By Company
Merck
Sandoz
Glenmark Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group
Qilu Pharmaceutical
Camber Pharma
Segment by Type:
80mg
125mg
Other
Segment by Application
Hospital
Pharmacy
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Aprepitant Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Aprepitant Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Aprepitant Capsules in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Aprepitant Capsules Product Introduction
1.2 Global Aprepitant Capsules Market Size Forecast
1.2.1 Global Aprepitant Capsules Sales Value (2019-2030)
1.2.2 Global Aprepitant Capsules Sales Volume (2019-2030)
1.2.3 Global Aprepitant Capsules Sales Price (2019-2030)
1.3 Aprepitant Capsules Market Trends & Drivers
1.3.1 Aprepitant Capsules Industry Trends
1.3.2 Aprepitant Capsules Market Drivers & Opportunity
1.3.3 Aprepitant Capsules Market Challenges
1.3.4 Aprepitant Capsules Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Aprepitant Capsules Players Revenue Ranking (2023)
2.2 Global Aprepitant Capsules Revenue by Company (2019-2024)
2.3 Global Aprepitant Capsules Players Sales Volume Ranking (2023)
2.4 Global Aprepitant Capsules Sales Volume by Company Players (2019-2024)
2.5 Global Aprepitant Capsules Average Price by Company (2019-2024)
2.6 Key Manufacturers Aprepitant Capsules Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Aprepitant Capsules Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Aprepitant Capsules
2.9 Aprepitant Capsules Market Competitive Analysis
2.9.1 Aprepitant Capsules Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Aprepitant Capsules Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aprepitant Capsules as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 80mg
3.1.2 125mg
3.1.3 Other
3.2 Global Aprepitant Capsules Sales Value by Type
3.2.1 Global Aprepitant Capsules Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Aprepitant Capsules Sales Value, by Type (2019-2030)
3.2.3 Global Aprepitant Capsules Sales Value, by Type (%) (2019-2030)
3.3 Global Aprepitant Capsules Sales Volume by Type
3.3.1 Global Aprepitant Capsules Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Aprepitant Capsules Sales Volume, by Type (2019-2030)
3.3.3 Global Aprepitant Capsules Sales Volume, by Type (%) (2019-2030)
3.4 Global Aprepitant Capsules Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Other
4.2 Global Aprepitant Capsules Sales Value by Application
4.2.1 Global Aprepitant Capsules Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Aprepitant Capsules Sales Value, by Application (2019-2030)
4.2.3 Global Aprepitant Capsules Sales Value, by Application (%) (2019-2030)
4.3 Global Aprepitant Capsules Sales Volume by Application
4.3.1 Global Aprepitant Capsules Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Aprepitant Capsules Sales Volume, by Application (2019-2030)
4.3.3 Global Aprepitant Capsules Sales Volume, by Application (%) (2019-2030)
4.4 Global Aprepitant Capsules Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Aprepitant Capsules Sales Value by Region
5.1.1 Global Aprepitant Capsules Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Aprepitant Capsules Sales Value by Region (2019-2024)
5.1.3 Global Aprepitant Capsules Sales Value by Region (2025-2030)
5.1.4 Global Aprepitant Capsules Sales Value by Region (%), (2019-2030)
5.2 Global Aprepitant Capsules Sales Volume by Region
5.2.1 Global Aprepitant Capsules Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Aprepitant Capsules Sales Volume by Region (2019-2024)
5.2.3 Global Aprepitant Capsules Sales Volume by Region (2025-2030)
5.2.4 Global Aprepitant Capsules Sales Volume by Region (%), (2019-2030)
5.3 Global Aprepitant Capsules Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Aprepitant Capsules Sales Value, 2019-2030
5.4.2 North America Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Aprepitant Capsules Sales Value, 2019-2030
5.5.2 Europe Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Aprepitant Capsules Sales Value, 2019-2030
5.6.2 Asia Pacific Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Aprepitant Capsules Sales Value, 2019-2030
5.7.2 South America Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Aprepitant Capsules Sales Value, 2019-2030
5.8.2 Middle East & Africa Aprepitant Capsules Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Aprepitant Capsules Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Aprepitant Capsules Sales Value
6.2.1 Key Countries/Regions Aprepitant Capsules Sales Value, 2019-2030
6.2.2 Key Countries/Regions Aprepitant Capsules Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Aprepitant Capsules Sales Value, 2019-2030
6.3.2 United States Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Aprepitant Capsules Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Aprepitant Capsules Sales Value, 2019-2030
6.4.2 Europe Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Aprepitant Capsules Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Aprepitant Capsules Sales Value, 2019-2030
6.5.2 China Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030
6.5.3 China Aprepitant Capsules Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Aprepitant Capsules Sales Value, 2019-2030
6.6.2 Japan Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Aprepitant Capsules Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Aprepitant Capsules Sales Value, 2019-2030
6.7.2 South Korea Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Aprepitant Capsules Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Aprepitant Capsules Sales Value, 2019-2030
6.8.2 Southeast Asia Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Aprepitant Capsules Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Aprepitant Capsules Sales Value, 2019-2030
6.9.2 India Aprepitant Capsules Sales Value by Type (%), 2023 VS 2030
6.9.3 India Aprepitant Capsules Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Aprepitant Capsules Product Offerings
7.1.5 Merck Recent Development
7.2 Sandoz
7.2.1 Sandoz Company Information
7.2.2 Sandoz Introduction and Business Overview
7.2.3 Sandoz Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sandoz Aprepitant Capsules Product Offerings
7.2.5 Sandoz Recent Development
7.3 Glenmark Pharmaceuticals
7.3.1 Glenmark Pharmaceuticals Company Information
7.3.2 Glenmark Pharmaceuticals Introduction and Business Overview
7.3.3 Glenmark Pharmaceuticals Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Glenmark Pharmaceuticals Aprepitant Capsules Product Offerings
7.3.5 Glenmark Pharmaceuticals Recent Development
7.4 Chia Tai Tianqing Pharmaceutical Group
7.4.1 Chia Tai Tianqing Pharmaceutical Group Company Information
7.4.2 Chia Tai Tianqing Pharmaceutical Group Introduction and Business Overview
7.4.3 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Chia Tai Tianqing Pharmaceutical Group Aprepitant Capsules Product Offerings
7.4.5 Chia Tai Tianqing Pharmaceutical Group Recent Development
7.5 Qilu Pharmaceutical
7.5.1 Qilu Pharmaceutical Company Information
7.5.2 Qilu Pharmaceutical Introduction and Business Overview
7.5.3 Qilu Pharmaceutical Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Qilu Pharmaceutical Aprepitant Capsules Product Offerings
7.5.5 Qilu Pharmaceutical Recent Development
7.6 Camber Pharma
7.6.1 Camber Pharma Company Information
7.6.2 Camber Pharma Introduction and Business Overview
7.6.3 Camber Pharma Aprepitant Capsules Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Camber Pharma Aprepitant Capsules Product Offerings
7.6.5 Camber Pharma Recent Development
8 Industry Chain Analysis
8.1 Aprepitant Capsules Industrial Chain
8.2 Aprepitant Capsules Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Aprepitant Capsules Sales Model
8.5.2 Sales Channel
8.5.3 Aprepitant Capsules Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Merck
Sandoz
Glenmark Pharmaceuticals
Chia Tai Tianqing Pharmaceutical Group
Qilu Pharmaceutical
Camber Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂